Table 1

Clinicopathological features of patients with CD20-positive NK/T-cell lymphoma described in present and previous reports
No. Authors (yr.) Diagnosis Age (year)/ Gender Clinical Presentation Immunophenotype Molecular analysis Treatment Outcome
1 Ando, et al. (2008) [26] Extranodal NK/T cell ymphoma, nasal type 71/Male (Japanese) Ulcerative mass in the right thenar prominence and a subcutaneous mass in right inguinal region CD20+, CD2+, CD3+, CD56+, TIA-1+, granzyme B+, CD4-, CD5-, CD7-, CD8-, CD10- EBERs (+); TCR β (−); TCR γ(−); TCR δ (−); IgH (−) Chemotherapy with CHOP, ESHAP, and L-asparaginase Progressive disease without remission and death in 6 months
2 Gill, et al. (2010) [27] Disseminated NK/T cell lymphoma 25/Male, (Chinese) Hypermetabolic lesion in right chest wall, head and neck lymph node, left adrenal gland, peritoneum, liver and the right anterior nasal cavity CD20 focal +, CD2+, CD45RO+, CD56+, TIA-1+, CD4-, CD5-, CD8-, CD79a-, PAX5-, Oct2-, BOB.1-, CD138- EBERs (+); TCR β (−); TCR γ(−); IgH (−) Not reported Not reported
3 Present case Extranodal NK/T cell lymphoma, nasal type 78/Female (Chinese) A solid mass in the left nasal cavity for 10 years CD20+, CD2+, CD3+, CD56+, CD8+, TIA-1+, granzyme B+, CD79a-, CD30-, PAX5-, CD138- EBERs (+); TCR γ(−); IgH (−) No treatment 6-months follow-up, alive

Jiang et al.

Jiang et al. Diagnostic Pathology 2012 7:133   doi:10.1186/1746-1596-7-133

Open Data